Traditional ethics provide insight, but often fall short of guiding the complex biomedical ethical concerns of research conducted in developing countries. The need to create research within a framework that is appropriate to the social, medical, and political context of developing countries is examined through the current AIDS pandemic in sub-Saharan Africa. A specific case study focuses on this issue.
World Health Organization. Safe and effective use of antiretroviral treatment in adults with particular references to resource limited settings. Initiative on HIV/AIDS and Sexually transmitted Infections. 2000. Geneva, Switzerland. Accessed March 31, 2003 at: http://whqlibdoc.who.int/hq/2000/WHO_HSI_2000.04.pdf.
2.
Slack C, Lindegger G. Ethical issues in HIV vaccine trials. XIII International AIDS Conference. July 9-14, 2000. Durban, South Africa. (Abstract WePpE1421). Accessed March 29, 2003 at: http://www.iac2000.org/abdetail.asp?ID=WePpE1421
3.
Abdool Karim SS. Globalization, ethics, and AIDS vaccines. Science2000; 288(5474):2129.
4.
Nuffield Council on Bioethics. The ethics of healthcare-related research in developing countries. Consultation Document, July 24, 2000.
5.
UNAIDS. Together We Can: Leadership in a world of AIDS. June 22, 2001. Geneva, Switzerland. Accessed April 23, 2003 at: http://www.unaids.org/UNGASS/index.html
6.
Essex M.The “New” AIDS Epidemic: It’s Raging Across Southern Africa Now, and is Spread Heterosexually. Harvard Magazine, September-October, 1999. Accessed April 23, 2003 at: http://www.harvard-magazine.com/issues/so99/forum.html
7.
Karstaedt A, Tennyson C, Kinghorn A, Schneider H. Care of Infected Adults at Baragwanth Hospital, Soweto. SAMJ1996; S6(11):1490-1493.
8.
Osborne CM, van Praag E, Jackson H. Models of care for patients with HIV/AIDS. AIDS1997; 11(Suppl B):S135 - S141.
9.
Bennett CL, Garfinkle JB, Greenfield S, et al.The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA1989; 261(20):2975-2979.
10.
Coker RJ, Poznansky MC. Physicians’ experience and survival in patients with AIDS. N Engl J Med1996; 335(5):349-351.
11.
Van de Perre. From research to programs: An overview of the research and ethics perspectives around mother-to-child transmission. IAPAC Proceedings. 1999. 3rd ICHRA Vienna.
12.
Sachs J.Mobilising science: Medicines for development, medicines for the poor. WTO Report. 1999:25-35.
13.
Etiebet MA, Fransman D, et al.Pregnant women opt for participation in district service-based interventions to reduce perinatal HIV transmission in Khayelitsha (Cape Town), South Africa. XIII International AIDS Conference. July 9-14, 2000. Durban, South Africa. (Abstract ThPpC1447). Accessed April 23, 2003 at: http://www.iac2000.org/abdetail.asp?ID=ThPpC1447
14.
Medical Research Council of South Africa. Ethical Considerations for HIV/AIDS Clinical and Epidemiological Research. 1999.
15.
Richter L, Lindegger, G, Abdool Karim Q, Gasa N. Guidelines for the development of culturally sensitive approaches to obtaining informed consent for participation in HIV vaccine-related trials. Discussion paper, University of Natal, 1999. Accessed April 23, 2003 at: www.hs.unp.ac.za/mind/icunaids.htm
16.
Faculty of Pharmaceutical Medicine, London, UK. Guiding Principles: Ethics and Pharmaceutical Medicine. International Journal of Pharmaceutical Medicine2000; 14:163-171. Accessed April 24, 2003 at: www.fpm.org.uk/Committees/ethical%2520issues%2520committee%2520main%2520text.htm
17.
Wilfert-Katz C and Hirsch, M. Prevention of HIV-1 mother-to-child transmission. IAS Position Paper. July, 1999.
18.
Guay LA, Musoke P, Fleming T, et al.Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet1999; 354(9181): 795-802.
19.
Chassany O, Duracinsky M. Ethics and Clinical Trials. Fundam Clin Pharmacol1999; 13(4):437-444. Review.
20.
CDC. The global HIV and AIDS epidemic. MMWR Morb Mortal Wkly Rep2001; 50(21):434-439. Accessed April 23 at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5021a3.htm
21.
Laurence J.AIDS: 20th Anniversary. AIDS Read2001; 11(6): 296-297.
22.
Schwartlander B, Stover J, Walker N, et al.AIDS: Resource needs for HIV/AIDS. Science2001; 292(5526):2434-2436.
23.
Phanuphak P, Thisyakorn U, Sirivichayakul S, et al.The Thai Red Cross donation campaign to prevent mother-to-child transmission of HIV. Program on AIDS, Thai Red Cross Society, Bangkok, Thailand. 12th World AIDS Conference. June 28-July 3, 1998. Geneva, Switzerland. (Abstract 23278).
24.
Boyle B.HIV in developing countries: A tragedy only starting to unfold. The AIDS Reader2000; 10(2):77-79.
25.
Global Forum for Health Research. The 10/90 Report on Health Research 2000. Accessed April 23, 2003 at: http://www.globalforumhealth.org/pages/page1_00060002_1.htm
26.
WHO. Operational Guidelines for Committees That Review Biomedical Research. 2000. Geneva, Switzerland. Accessed April 23, 2003 at: http://www.who.int/tdr/publications/publications/pdf/ethics.pdf
27.
Wells V, La Rosa J. Gender and HIV/AIDS in east and southern Africa (ESA): Are women “getting what they deserve”?XI International Conference on AIDS. July 7-12, 1996. Vancouver, Canada. (Abstract Th.C.4833).
28.
Abdool Karim QA, Abdool Karim SS, Coovadia HM, et al.Informed consent for HIV testing in a South African hospital: Is it truly informed and truly voluntary?Am J Public Health1998; 88(4):637-640.
29.
UNAIDS. Ethical considerations in HIV preventative vaccine research. UNAIDS guidance document. May, 2000. Geneva, Switzerland. Accessed April 23, 2003 at: http://www.unaids.org/publications/documents/vaccines/vaccines/Ethicsresearch.pdf
